BridgeBio’s GondolaBio bet skirts industry’s focus on small pipelines

BridgeBio has been quietly building a sprawling pipeline at its private spinout GondolaBio. The rare disease startup launched last year with a few of BridgeBio’s rare disease assets and $300 million in ...